Loading…

The role of lipins in innate immunity and inflammation

Lipins are phosphatidic acid phosphatase enzymes whose cellular function in regulating lipid metabolism has been known for decades, particularly in metabolically active tissues such as adipose tissue or liver. In recent years evidence is accumulating for key regulatory roles of the lipin family in i...

Full description

Saved in:
Bibliographic Details
Published in:Biochimica et biophysica acta. Molecular and cell biology of lipids 2019-10, Vol.1864 (10), p.1328-1337
Main Authors: Balboa, María A., de Pablo, Nagore, Meana, Clara, Balsinde, Jesús
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Lipins are phosphatidic acid phosphatase enzymes whose cellular function in regulating lipid metabolism has been known for decades, particularly in metabolically active tissues such as adipose tissue or liver. In recent years evidence is accumulating for key regulatory roles of the lipin family in innate immune cells. Lipins may help regulate signaling through relevant immune receptors such as Toll-like receptors, and are also integral part of the cellular machinery for lipid storage in these cells, thereby modulating certain inflammatory processes. Mutations in genes that encode for members of this family produce autoinflammatory hereditary diseases or diseases with an important inflammatory component in humans. In this review we summarize recent findings on the role of lipins in cells of the innate immune system and in the onset and progress of inflammatory processes. •Lipins have been described as modulators of inflammatory responses.•Lipin-1 and -2 antagonistically regulate immune signaling in myeloid cells.•Lipin-1 participates in the development of inflammatory and metabolic diseases.•Lipin-2 controls inflammasome assembly and prevents autoinflammatory disorders.
ISSN:1388-1981
1879-2618
DOI:10.1016/j.bbalip.2019.06.003